After Mollycoddling China Cracks Down on Pharma MNCs…But Why Now?

In tandem with exemplary growth in the healthcare sector, China has started confronting with some consequential hazards in form of serious regulatory violations involving, besides many others, hospitals, pharmaceutical pricing and food and drug safety, which reportedly include contaminated milk powder and … Continue reading

‘The Pharmacy of the Developing World’ keeps its eye on the ball to emerge as ‘The Pharmacy of the World’

The incessant march of the home grown pharmaceutical companies of India in search of excellence, especially in the space of high quality low cost generic medicines for almost all disease areas, continues at a scorching space, probably more than ever … Continue reading

A Kaleidoscope of Drug Price Control Spanning Across the World and Its Relevance to India

How much to charge for a drug? While there is no single or only right way to arrive at the price of a medicine, how much the pharmaceutical manufacturers will charge for a drug still remains an important, yet complex … Continue reading

Encourage vaccine research and improve its access to demonstrate ‘prevention is better than cure’

Vaccines are one of the most successful and cost-effective public health interventions, which help preventing over 2 million deaths every year. The World Health Organization (WHO) defines vaccines as: “A vaccine is any preparation intended to produce immunity to a … Continue reading

The ‘Climate Change’ and its impact on ‘Public health’: is there anything in it that we can do ourselves?

The Lancet in its December 5, 12 and 19, 2009 issues published the following interesting studies:A. Public health benefits of strategies to reduce greenhouse-gas emissions: household energy B. Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport … Continue reading

To restore patients’ confidence MCI has amended its regulations… to strengthen it further will the government consider an Indian version of ‘Physician Payment Sunshine Act’?

In today’s India, blatant commercialization of the noble healthcare services has reached its nadir, as it were, sacrificing the ethics and etiquettes both in medical and pharmaceutical marketing practices at the altar of unlimited greed. As a result of fast … Continue reading

Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality

THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in … Continue reading

Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality

THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in … Continue reading